[CHLA] – House Research Institute and Children’s Hospital Los Angeles have announced an international consortium with the University of Verona in Italy to collaborate on teaching and research to advance the use of the Auditory Brainstem Implant (ABI) in children worldwide. The ABI is already used successfully in Italy with the pediatric population and the goal of the partnership is to bring the hearing implants to deaf children in the United States.
House Research Institute and Children’s Hospital Los Angeles have submitted an application to the United States Federal Drug Administration (FDA) to start implanting the ABI in children in the U.S.
“We are excited about partnering with Children’s Hospital and the University of Verona to accelerate the progress of auditory brainstem implantation (ABI) in U.S. Children,” said Eric Wilkinson, M.D., co-principal investigator at House Research Institute and associate physician at House Clinic. “Children’s Hospital’s experience with pediatric intracranial procedures and University of Verona’s experience with ABI are unparalleled. Combined with House Research Institute’s surgical experience with ABIs and audiological experience in children, the team is ready to maximize ABI outcomes for pediatric patients.”
Some children are born with no hearing nerve and cannot be helped by a hearing aid or a cochlear implant. The ABI bypasses the inner ear and hearing nerve to stimulate the brainstem directly allowing the brain to hear sound.
“Children’s Hospital Los Angeles is privileged and honored to be able to offer this innovative procedure to children in the United States,” says pediatric neurosurgeon Mark Krieger, MD, chief of Medical Staff, Children’s Hospital Los Angeles. Krieger also holds a position as chief of the hospital’s Division of Pediatric Neurosurgery. “The ABI has shown great success providing sound to deaf children and deaf adults and we will contribute to research on advancing the ABI and to the education of physicians on the surgical implantation techniques.”